Vir Biotechnology, Inc.VIRNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank38
3Y CAGR+91.7%
5Y CAGR-22.8%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+91.7%/yr
vs -81.9%/yr prior
5Y CAGR
-22.8%/yr
Recent acceleration
Acceleration
+173.6pp
Accelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 11.50 | -2.5% |
| 2024 | 11.79 | -17.5% |
| 2023 | 14.30 | +776.6% |
| 2022 | 1.63 | -65.8% |
| 2021 | 4.77 | -88.6% |
| 2020 | 42.01 | -97.6% |
| 2019 | 1751.23 | +15.0% |
| 2018 | 1522.18 | +351.6% |
| 2017 | -605.03 | - |